Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Publication year range
1.
Gan To Kagaku Ryoho ; 35(7): 1243-5, 2008 Jul.
Article in Japanese | MEDLINE | ID: mdl-18633273

ABSTRACT

Clear-cell carcinoma of the ovary is a highly malignant neoplasm. Survival of patients in the advanced stage is poor, and the best treatment is not clear. We report here a case of a 57-year-old woman who had Stage IIIb advanced clearcell carcinoma of the ovary. We performed abdominal hysterectomy, bilateral salpingo-oophorectomy, pelvic lympho adenectomy and partial omentectomy. After the operation she was placed on induction and maintenance chemotherapy with a combination of irinotecan(CPT-11)(60 mg/m2, day 1, 15)plus cisplatin(CDDP)(60 mg/m2, day 1). Four years after surgery, a metastatic tumor was found in the brain. Considering the poor prognosis of clear-cell carcinoma, this regimen is thought to be effective for advanced clear-cell carcinoma of the ovary. It is important to check brain metastases under maintenance chemotherapy.


Subject(s)
Adenocarcinoma, Clear Cell/drug therapy , Adenocarcinoma, Clear Cell/pathology , Brain Neoplasms/drug therapy , Camptothecin/analogs & derivatives , Cisplatin/therapeutic use , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/pathology , Adenocarcinoma, Clear Cell/diagnostic imaging , Adenocarcinoma, Clear Cell/surgery , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/secondary , Camptothecin/therapeutic use , Female , Humans , Irinotecan , Middle Aged , Neoplasm Staging , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/surgery , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...